Klippel‐Trenaunay Syndrome with a Life‐Threatening Thromboembolic Event

Kamal Aggarwal(Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences), Vishal Goyal(Chandigarh University), Vijay Kumar Jain(Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences), Hari K. Aggarwal(Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences), Sanjeev Gupta(Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences), Jyotsna Sen(Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences)
The Journal of Dermatology
March 1, 2003
10.1111/j.1346-8138.2003.tb00378.x
Cited by 25

Related Papers

Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives
|Clinical Microbiology Reviews|2018|218
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
|PLoS neglected tropical diseases|2017|78
Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis
|BMC Public Health|2017|72
AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial
|Clinical Infectious Diseases|2022|53
Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial
|˜The œLancet. Gastroenterology & hepatology|2021|42